4 recruiting. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 4 |
| Phase 1 | 2 | Recruiting 2 |
Follow Olfactory Nerve Diseases: new trials by email Literature Review of Olfactory Nerve Diseases trials Research Report on Olfactory Nerve Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy - Melanoma, Medullary Thyroid Cancer | Phase 1 / Phase 2 | Recruiting | University of Arizona | 30 | 2025-09-08 | 2026-10-06 |
| Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). Olaparib; 177Lu-DOTATATE - Solid Tumor Cancer, Medulloblastoma | Phase 1 / Phase 2 | Recruiting | Fundación de investigación HM | 25 | 2024-09-20 | 2026-06-04 |
| Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors Enasidenib - Metastatic Chondrosarcoma, Locally Advanced Chondrosarcoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 40 | 2024-03-04 | 2026-11-05 |
| Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON) Gemcitabine+Cisplatin(GP); Cyclophosphamide+Etoposide+Cisplatin(CEP) - Olfactory Neuroblastoma | Phase 2 | Recruiting | Hongmeng Yu | 25 | 2024-03-01 | 2024-02-13 |
Esthesioneuroblastoma, Olfactory (4) · Glioblastoma (2) · Sinonasal undifferentiated carcinoma (2) · Adrenal Cortex Neoplasms (1) · Adrenal Gland Neoplasms (1) · Carcinoma, Medullary (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Chondrosarcoma (1) · Ependymoma (1) · Glioma (1) · Medulloblastoma (1) · Melanoma (1) · Meningioma (1) · Neuroblastoma (1)
Cranial Nerve Diseases (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Nerve Tissue (4) · Neoplasms, Neuroepithelial (4) · Nervous System Diseases (4) · Neuroectodermal Tumors (4) · Neuroectodermal Tumors, Primitive (4) · Neuroectodermal Tumors, Primitive, Peripheral (4) · Neuroblastoma (3) · Astrocytoma (2) · Endocrine Gland Neoplasms (2)
enasidenib (1) · lutetium Lu 177 dotatate (1) · olaparib (1)
Fundación de investigación HM (1) · Hongmeng Yu (1) · National Cancer Institute (NCI) (1) · University of Arizona (1)
United States (2) · China (1) · Spain (1)
Charalampos Floudas, M.D. (1) · Charles Hsu, MD (1) · Hongmeng Yu, Prof. (1) · Marta Osuna Marco, PhD (1) · Ricklie Julian, MD (1) · Xicai Sun, MD (1)